dr. muss on the role of parp inhibitors in breast cancer
Published 6 years ago • 48 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
6:10
role of parp inhibition and i/o therapy in tnbc
-
4:59
future role of parp inhibition in brca breast cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
1:35
dr. muss on maximizing cardiac function in breast cancer patients
-
3:31
distinguishing between parp inhibitors in breast cancer
-
18:32
usmle ace video 261: breast pathologies - common benign disorders and malignant tumors
-
3:44
the future role of parp inhibition in ovarian cancer
-
1:13
addressing the role of parp inhibitors in different breast cancer settings
-
7:42
parp inhibitors in other subtypes of breast cancer
-
1:25
dr. lynce on remaining questions with parp inhibitors in breast cancer
-
27:25
opportunities and challenges in early breast cancer: do parp inhibitors have a role?
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
0:47
dr. morgan on the role of parp inhibitors in prostate cancer
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
1:17
dr. traina on parp inhibition in brca-mutated breast cancer
-
1:15
dr. robson on the toxicity profile of olaparib in breast cancer
-
1:00
dr. chandarlapaty on role of the pi3k pathway in breast cancer